title: Aprepitant versus dexamethasone to prevent delayed emesis after chemotherapy.
authors.affiliation: University of Ottawa, Ottawa, Ontario, Canada teng@toh.on.ca.
authors.forename: Terry L
authors.initials: TL
authors.lastname: Ng
authors.affiliation: University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Mark
authors.initials: M
authors.lastname: Clemons
authors.affiliation: Ottawa Hospital Research Institute; University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Brian
authors.initials: B
authors.lastname: Hutton
authors.affiliation: University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: George
authors.initials: G
authors.lastname: Dranistaris
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D009025:Morpholines; D003907:Dexamethasone